Keywords: humira, discussed, eular, congress, health, care, major

Humira in AS discussed at EULAR congress

Article | 03 July 2006

Print This

US health care major Abbott Laboratories says that data from a Phase III trial of Humira (adalimumab), its tumor necrosis ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in